Publication & Citation Trends
Most Cited Works
Publications
126 total
Efficacy of Poly(ADP-ribose) Polymerase Inhibitors by Individual Genes in Homologous Recombination Repair Gene-Mutated Metastatic Castration-Resistant Prostate Cancer: A US Food and Drug Administration Pooled Analysis PDF
Cited by 71
OpenAlex
Systematic Review of PD-1/PD-L1 Inhibitors in Oncology: From Personalized Medicine to Public Health PDF
Cited by 85
OpenAlex
Discovery of Acyl-sulfonamide Na<sub>v</sub>1.7 Inhibitors GDC-0276 and GDC-0310 PDF
Cited by 38
OpenAlex
Modernizing Clinical Trial Eligibility Criteria: Recommendations of the ASCO-Friends of Cancer Research Laboratory Reference Ranges and Testing Intervals Work Group PDF
Cited by 36
OpenAlex
FDA Approval Summary: Enfortumab Vedotin for Locally Advanced or Metastatic Urothelial Carcinoma PDF
Cited by 180
OpenAlex
FDA Approval Summary: Rucaparib for the Treatment of Patients with Deleterious <i>BRCA</i>-Mutated Metastatic Castrate-Resistant Prostate Cancer PDF
Cited by 69
OpenAlex
Selective NaV1.7 Antagonists with Long Residence Time Show Improved Efficacy against Inflammatory and Neuropathic Pain PDF
Cited by 76
OpenAlex
Research Topics
Cancer Immunotherapy and Biomarkers
(37)
Bladder and Urothelial Cancer Treatments
(36)
Renal cell carcinoma treatment
(26)
Urinary and Genital Oncology Studies
(15)
Ion channel regulation and function
(12)
Frequent Co-Authors
Affiliations
Michael E. DeBakey VA Medical Center
Center for Veterinary Medicine
United States Food and Drug Administration
Center for Drug Evaluation and Research
Agilent Technologies (United States)